BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference

CPhI WW will be held in Frankfurt, Germany from November 1 to November 3, 2022. The conference will focus on product sustainability and innovation across t...

October 21, 2022 | News

With New Commitment, Gates Foundation Joins Call to Help End Polio

The new financial commitment will support implementation of the GPEI's Polio Eradication Strategy 2022-2026, which aims to end wild poliovirus in the ...

October 17, 2022 | News

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the...

October 13, 2022 | News

Lilly receives U.S. FDA Fast Track designation for tirzepatide

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investig...

October 11, 2022 | News

Merck Announced Its Intention To Further Expand Its Leadership in Science and Technology

“Big 3” expected to generate around 80% of sales growth and > 50% of total sales in 2025 Strategic and targeted investments for annu...

October 11, 2022 | News

Emmes (CRO) Acquires Clinical Edge

- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical in...

September 30, 2022 | News

Pall Corporation Launches Three New Allegro™ Connect Systems

Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...

September 28, 2022 | News

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...

September 27, 2022 | News

Sciwind Biosciences and SynerK Enter into Research Partnership

The partnership combines Sciwind's expertise in disease biology and clinical development capabilities with SynerK's proprietary conjugate-based siRNA deliv...

September 27, 2022 | News

Biocytogen Expands Partnership with Merck

Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...

August 29, 2022 | News

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...

August 24, 2022 | News

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapi...

August 23, 2022 | News

BD, Accelerate Diagnostics Announce Global Commercial Collaboration

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Accelerate Diagnostics, Inc. (NASDAQ:...

August 15, 2022 | News

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...

August 09, 2022 | News

Stay Connected